ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Biome Technologies Plc

Biome Technologies Plc (BIOM)

4.00
0.00
(0.00%)
Closed January 05 11:30AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
4.00
Bid
3.50
Ask
4.50
Volume
50,000
4.00 Day's Range 4.00
2.50 52 Week Range 130.00
Market Cap
Previous Close
4.00
Open
4.00
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
37,181
Shares Outstanding
51,555,814
Dividend Yield
-
PE Ratio
-1.32
Earnings Per Share (EPS)
-0.03
Revenue
6.98M
Net Profit
-1.56M

About Biome Technologies Plc

Sector
Manufacturing Industries,nec
Industry
Manufacturing Industries,nec
Headquarters
Hampshire, Gbr
Founded
-
Biome Technologies Plc is listed in the Manufacturing Industries sector of the London Stock Exchange with ticker BIOM. The last closing price for Biome Technologies was 4p. Over the last year, Biome Technologies shares have traded in a share price range of 2.50p to 130.00p.

Biome Technologies currently has 51,555,814 shares outstanding. The market capitalization of Biome Technologies is £2.06 million. Biome Technologies has a price to earnings ratio (PE ratio) of -1.32.

BIOM Latest News

Biome Technologies PLC Secured Funding Facility

Biome Technologies PLC 18 December 2024   This announcement contains inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With...

Biome Technologies PLC Trading Update and Board Change

Biome Technologies PLC 04 December 2024   This announcement contains inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With...

Biome cuts revenue forecast amid challenges as chair steps down

Biome Technologies PLC, a Southampton-based bioplastics developer, issued a trading update for the quarter ending Sep ...

Biome Technologies PLC Trading Update

Biome Technologies PLC 13 November 2024   This announcement contains inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With...

EXECUTIVE CHANGES: New Scancell, Nanoco and LPA CEOs; Coral CEO exits

The following is a round-up of London-listed company director and manager changes announced this week and not separat ...

Biome Technologies PLC Appointment of Non-Executive Director

Biome Technologies PLC 25 October 2024   25 October 2024 Biome Technologies plc ("Biome", the "Group" or the "Company") Appointment of Non-Executive Director   Biome Technologies plc, a...

Biome Technologies PLC Total Voting Rights

Biome Technologies PLC 30 September 2024     30 September 2024   Biome Technologies plc ("Biome", the "Company" or the "Group")   Total Voting Rights   Biome Technologies plc, a leading...

Biome Technologies PLC Contract win for Stanelco RF Division

Biome Technologies PLC 30 September 2024     30 September 2024   Biome Technologies plc ("Biome", the "Company" or the "Group")   Contract win for Stanelco RF Division   Biome Technologies...

Biome Technologies amends bioplastics outlook as interim profit falls

Biome Technologies PLC on Friday said its revenue for the first half of 2024 has fallen by more than a third, as it c ...

Biome Technologies PLC Interim Results

Biome Technologies PLC 20 September 2024   This announcement contains inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.25-5.882352941184.254.2541026294.21437341DE
4-0.5-11.11111111114.54.754525694.3478156DE
12-3-42.8571428571772.5371815.20989441DE
26-66-94.285714285770752.5335139.69545793DE
52-103.5-96.2790697674107.51302.51871817.63597963DE
156-306-98.70967741943103502.5965650.93458357DE
260-276-98.57142857142805052.58143120.26599244DE

BIOM - Frequently Asked Questions (FAQ)

What is the current Biome Technologies share price?
The current share price of Biome Technologies is 4.00p
How many Biome Technologies shares are in issue?
Biome Technologies has 51,555,814 shares in issue
What is the market cap of Biome Technologies?
The market capitalisation of Biome Technologies is GBP 2.06M
What is the 1 year trading range for Biome Technologies share price?
Biome Technologies has traded in the range of 2.50p to 130.00p during the past year
What is the PE ratio of Biome Technologies?
The price to earnings ratio of Biome Technologies is -1.32
What is the cash to sales ratio of Biome Technologies?
The cash to sales ratio of Biome Technologies is 0.3
What is the reporting currency for Biome Technologies?
Biome Technologies reports financial results in GBP
What is the latest annual turnover for Biome Technologies?
The latest annual turnover of Biome Technologies is GBP 6.98M
What is the latest annual profit for Biome Technologies?
The latest annual profit of Biome Technologies is GBP -1.56M
What is the registered address of Biome Technologies?
The registered address for Biome Technologies is NORTH ROAD, MARCHWOOD INDUSTRIAL PARK, MARCHWOOD, HAMPSHIRE, SO40 4BL
What is the Biome Technologies website address?
The website address for Biome Technologies is www.biometechnologiesplc.com
Which industry sector does Biome Technologies operate in?
Biome Technologies operates in the MANUFACTURING INDUSTRIES,NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discussion

View Full Feed
Mr. Bill Mr. Bill 8 minutes ago
https://www.medicinenet.com/what_are_blood_oxygen_levels/article.htm
devil dog 96 devil dog 96 9 minutes ago
Tell everyone why you think they never took the 39 million shares off restriction if they need shares to dump? Why have they not taken 1 share off restriction since early 2021 if they need shares to dump?? Why would they issue new shares that will be unregistered and also have to wait a year before
ATMH
CrossFireTrader CrossFireTrader 9 minutes ago
Page 22 of 26, and If say I'm Bullish that'll set 280e off, and I'll  be accused of pumping our little lottery ticket. I'm here for the long haul. I'm not here to sell at 0.016 or 0.02 or 0.03 or whatever his new price is. He actually likes GDVM a lot more than he lets on. Since you seem to be somew
GDVM
Mr. Bill Mr. Bill 13 minutes ago
https://measuringmyhealth.com/what-is-a-normal-pi-on-a-pulse-oximeter/
georgejjl georgejjl 13 minutes ago
That is WRONG. The current standard of care is donepezil (Aricept) and memantine, etc.

MAB's still are an extremely small number of treatments for Alzheimer's in the USA and worldwide.

Good luck and GOD bless,
AVXL
axelvento axelvento 33 minutes ago
Q1 the first interim analysis of the vaccine’s efficacy is expected

Moderna’s mRNA-1647
Cytomegalovirus
MRNA
MightyX MightyX 36 minutes ago
Yet no one is innocent
TPTW
BIG D 4 BIG D 4 37 minutes ago
WOW !! HAPPY NEW YEAR TO ALL THE LONGS HERE !! I HAVE 2 NAYSAYERS ON IGNORE SO I NEVER READ THEIR BS !! GO SAVING GRACE-- JJ AND ALL THE NEW POSTERS WHO ARE POSITIVE !! .02 CENTS TO START THE RUN TO ONE DOLLAR IS WHERE WE SHOULD BE !! THIS STOCK IS SUCH A GREAT BUY HERE !! I AM LOADED WITH 32 MILLI
MJNA
MightyX MightyX 37 minutes ago
The judicial system legitimizes prosecution
TPTW
jondoeuk jondoeuk 38 minutes ago
A new paper. From it: 'BNT221 was well tolerated across both DLs, with no dose-limiting toxicities of grade 3 or higher attributed to the T cell product observed. Specifically, no cytokine release, immune effector cell-associated neurotoxicity or macrophage activation syndromes were reported. A dose
BNTX
benz280c benz280c 40 minutes ago
Nice to see you are bullish. This quote may round out your knowledge.
"It is worthy to note that a new CUSIP has been approved by the CUSIP Global Services (CGS).
Subsequently, we have submitted a corporation action with FINRA for a Company name change, Ticker Symbol Change and Cusip
GDVM
shajandr shajandr 40 minutes ago
Sorry to read that you're still feeling sick. I posted a week or two ago about 41 bunnies and also some cats and dogs that were rescued from a home in Delaware county, Iowa and that were transferred to the DBQ county animal shelter. I just spoke with DaSqu_w and she went to the animal shelter to see
Lakota-45 Lakota-45 41 minutes ago
Will do, but I doubt they will listen !!!

~ Lol !!!
IONI
boi568 boi568 43 minutes ago
Probably
AVXL
HokieHead HokieHead 45 minutes ago
Wrong..
TWOH
HokieHead HokieHead 45 minutes ago
Get your facts straight, the halt was in the Canadian side as they are reviewing all the disclosures submitted, there’s ZERO issues in the US, it’s a fully reporting SEC company.
TWOH
Lakota-45 Lakota-45 47 minutes ago
I agree with you 'farmI1234 !!!

I'm pretty sure most of the Savvy Investors, that have been paying attention,
have been loading the dips, and .0004's, for a while now.
I know I have, along with fishing down stream.

I doubt any Longs will get caught short,
WDLF
CaptHowdy CaptHowdy 48 minutes ago
RECOMMENDED.... nothing is offical yet, unnecessary twisting of facts to bolster your negative viewpoints. Thats news is two months old
GRLT
axelvento axelvento 48 minutes ago
Cancer vaccines: What’s ahead in 2025

The spotlight is on mRNA-4157 (V940)

https://gulfnews.com/special-reports/cancer-vaccines-whats-ahead-in-2025-1.500010233
MRNA
facts_matter14 facts_matter14 49 minutes ago
Does this sound like a company with 16 products and a 17th on the way?

https://investorshub.advfn.com/uimage/uploads/2024/12/24/mwowsIMG_6034.png








.
SRMX
HomerRomer HomerRomer 50 minutes ago
More testimony videos from trial participants like the Australian news reel of Ern Heaven would be amazing. I would think that most of the people involved 9 years ago in the earlier phase studies have passed on since the average life expectancy is normally between 3-11 years after being diagnosed w
AVXL
CaptHowdy CaptHowdy 51 minutes ago
That's how to make money on the OTC. 🤦🏻‍♂️ Anyone could do it; only if the effort spent discounting the new leadership in place along with the turn around story underway was used to turn a profit vs. using 9yr old DD to bad mouth new CEO.
GRLT
crescentmotor crescentmotor 51 minutes ago
I think that is a bad precedent to start.

100% on parading a handful of Blarcamesine patients at the JPM conference. I highly doubt AVXL would involve itself with anecdotal gimmicks where there is no way possible to extrapolate isolated successes to meaningful conclusions about broad
AVXL JPM

Your Recent History

Delayed Upgrade Clock